1-(5-Bromo-2-methyl-4-(methylsulfonyl)phenyl)piperidine-4-carboxamide
Names and Identifiers of 1000018-34-7
CAS Number |
1000018-34-7 |
|---|---|
MDL Number |
MFCD09264559 |
IUPAC Name |
1-(5-bromo-2-methyl-4-methylsulfonylphenyl)piperidine-4-carboxamide |
InChI |
InChI=1S/C14H19BrN2O3S/c1-9-7-13(21(2,19)20)11(15)8-12(9)17-5-3-10(4-6-17)14(16)18/h7-8,10H,3-6H2,1-2H3,(H2,16,18) |
InChIKey |
GBNWGFUNIFCJNH-UHFFFAOYSA-N |
Canonical SMILES |
CC1=CC(=C(C=C1N2CCC(CC2)C(=O)N)Br)S(=O)(=O)C |
UNSPSC Code |
12352100 |
Physical and chemical properties of 1000018-34-7
Acidity coefficient |
16.35±0.20(Predicted) |
|---|---|
Boiling Point |
638.5±55.0 °C at 760 mmHg |
Density |
1.5±0.1 g/cm3 |
Exact Mass |
374.029968 |
Flash Point |
339.9±31.5 °C |
Index of Refraction |
1.590 |
LogP |
0.43 |
Melting Point |
296~298℃ |
Molecular Formula |
C14H19BrN2O3S |
Molecular Weight |
375.281 |
Vapour Pressure |
0.0±1.9 mmHg at 25°C |
Safety Information of 1000018-34-7
Applications of 1000018-34-7
1-(5-Bromo-2-methyl-4-(methylsulfonyl)phenyl)piperidine-4-carboxamide has several applications in scientific research:
- Chemistry: It serves as a building block for synthesizing more complex organic molecules.
- Biology: The compound is being investigated for its interactions with enzymes and receptors, potentially leading to new insights in pharmacology.
- Medicine: Its therapeutic properties are under exploration, particularly in relation to pain management and inflammation control.
Interaction Studies of 1000018-34-7
The interaction studies involving 1-(5-Bromo-2-methyl-4-(methylsulfonyl)phenyl)piperidine-4-carboxamide focus on its binding mechanisms with specific molecular targets. These studies aim to elucidate how the compound alters the activity of certain receptors or enzymes, which could lead to the development of novel therapeutic agents. The exact pathways and biological effects depend on the context of use and specific targets studied.
Biological Activity of 1000018-34-7
While specific biological activities of 1-(5-Bromo-2-methyl-4-(methylsulfonyl)phenyl)piperidine-4-carboxamide are still under investigation, its structural components suggest potential interactions with biological targets. The presence of the bromine atom may enhance its binding affinity to certain receptors or enzymes through halogen bonding. This compound is being explored for its possible therapeutic properties, including anti-inflammatory and analgesic effects.
